Avateramedical GmbH Sustainability Profile
Avateramedical GmbH, a pioneering force in the field of digital health solutions, is headquartered in Germany and operates extensively across Europe. Founded in 2015, the company has rapidly established itself within the medical technology industry, focusing on innovative software solutions for personalised medicine and patient management. Avateramedical's core offerings include advanced telemedicine platforms and AI-driven diagnostic tools, designed to enhance patient care and streamline healthcare processes. What sets them apart is their commitment to integrating cutting-edge technology with user-friendly interfaces, ensuring accessibility for both healthcare professionals and patients. With a strong market position, Avateramedical has achieved significant milestones, including partnerships with leading healthcare institutions and recognition for their contributions to digital health innovation. Their dedication to improving healthcare outcomes continues to drive their growth and influence in the industry.
DitchCarbon Score
How does Avateramedical GmbH's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Avateramedical GmbH's score of 20 is lower than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Avateramedical GmbH's reported carbon emissions
Avateramedical GmbH, headquartered in Germany, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Avateramedical may still be in the early stages of developing its climate commitments or reporting practices. As the company does not inherit emissions data from a parent organisation, it operates independently in terms of its climate impact reporting. Without specific emissions figures or reduction initiatives, it is unclear how Avateramedical GmbH aligns with industry standards for carbon management and sustainability.
How Carbon Intensive is Avateramedical GmbH's Industry?
How Carbon Intensive is Avateramedical GmbH's Location?
Avateramedical GmbH's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Avateramedical GmbH has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
